aTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
25 Maggio 2023 - 2:00PM
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged
in the discovery and development of first-in-class medicines from
its proprietary tRNA synthetase platform, today announced that
Sanjay S. Shukla, M.D., M.S., President and Chief Executive
Officer, will present a corporate overview at the 2023 Jefferies
Healthcare Conference, which is scheduled to take place June 7 – 9,
2023, in New York, NY.
Details of the presentation appear below:
Conference: 2023 Jefferies Healthcare ConferenceDate: Thursday,
June 8, 2023 Time: 3:30pm EDTLocation: New York, NYFormat:
Corporate Presentation
In addition to the presentation, company
management will be available to participate in one-on-one meetings
with investors who are registered attendees of the conference. A
webcast of the event will be available on the Investor’s section of
the company’s website at www.atyrpharma.com. Following the event, a
replay of the presentation will be available on the aTyr website
for at least 90 days.
About aTyr
aTyr is a biotherapeutics company engaged in the
discovery and development of first-in-class medicines from its
proprietary tRNA synthetase platform. aTyr’s research and
development efforts are concentrated on a newly discovered area of
biology, the extracellular functionality and signaling pathways of
tRNA synthetases. aTyr has built a global intellectual property
estate directed to a potential pipeline of protein compositions
derived from 20 tRNA synthetase genes and their extracellular
targets. aTyr’s primary focus is efzofitimod, a clinical-stage
product candidate which binds to the neuropilin-2 receptor and is
designed to downregulate immune engagement in fibrotic lung
disease. For more information, please visit www.atyrpharma.com.
Contact:Ashlee DunstonDirector,
Investor Relations and Corporate
Communicationsadunston@atyrpharma.com
Grafico Azioni aTyr Pharma (NASDAQ:LIFE)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni aTyr Pharma (NASDAQ:LIFE)
Storico
Da Mag 2023 a Mag 2024